ARTICLE | Company News
Tengion genitourinary, gene/cell therapy, transplant news
January 5, 2015 8:00 AM UTC
Regenerative medicine company Tengion filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Tengion was developing Neo-Kidney Augment, a bioabsorbable scaffold see...